Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMZ3X7F)

Drug Name

Fordadistrogene movaparvovec Drug Info

Synonyms

PF-06939927

Indication

Disease Entry	ICD 11	Status	REF
Duchenne muscular dystrophy	8C70.1	Phase 3	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Dystrophin (DMD)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
WVE-210201	DMHXJ68	Duchenne dystrophy	8C70	Phase 2/3	[2]
SRP-9001	DMR09IH	Duchenne dystrophy	8C70	Phase 2	[3]
MyoDys	DMHO6XP	Duchenne dystrophy	8C70	Phase 1	[4]
Biostrophin	DMS4P6K	Duchenne dystrophy	8C70	Phase 1	[5]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

References

1	ClinicalTrials.gov (NCT05689164) Long-term Follow-up Safety and Efficacy Study in Participants With Duchenne Muscular Dystrophy Who Have Received Fordadistrogene Movaparvovec in a Preceding Clinical Study. U.S.National Institutes of Health.
2	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3	Clinical pipeline report, company report or official report of Sarepta Therapeutics.
4	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800009280)
5	Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches. Nat Rev Genet. 2013 Jun;14(6):373-8.